PPARγ up-regulates TGFβ/smad signal pathway repressor c-Ski

( views:54, downloads:0 )
Author:
LI Gong-Bo()
LI Jun()
ZENG Yi-Jun()
ZHONG Dan()
WU Geng-Ze()
FU Xiao-Hong()
HE Feng-Tian()
DAI Shuang-Shuang()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 63, Issue 01, 2011
DOI:
Key Word:

Abstract:

  • [1]Kersten S,Desvergne B,Wahli W.Roles of PPARs in health and disease.Nature 2000; 405(6785):421-424.
  • [2]Ghosh J,Murphy MO,Turner N,Khwaja N,Halka A,Kielty CM,WalkerMG.The role of transforming growth factor betal in the vascular systetu.Cardiovasc Pathol 2005; 14(1):28-36.
  • [3]Liu X,Li E Liu P,Xiong RP,Zhang E,Chen XY,Gu DY,Zhao Y,Wang ZG,Zhou YG.The essential role for c-Ski in mediating TGF-betal-induced bi-directional effects on skin fibroblast proliferation through a feedback loop.Biochem J 2008; 409(1):289-297.
  • [4]Suzuki H,Yagi K,Kondo M,Kato M,Miyazono K,Miyazawa K.c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smadbinding elements.Oncogene 2004; 23(29):5068-5076.
  • [5]Yang PY(杨鹏远),Rui YC,Jiao YB.Establishment of experimental atherosclerosis model in rats.Acad J Sec Mil Med Univ(第二军医大学学报)2003; 24(7):802-804(Chinese,English abstract).
  • [6]Macias-silva M,Li W,Leu JI,Crissey MA,Taub R.Upregulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.J Biol Chem 2002;277(32):28483-28490.
  • [7]Duan SZ,Usher MG,Mortensen RM.Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.Circ Res 2008; 102(3):283-294.
  • [8]Fu M,Zhang J,Lin Y,Zhu X,Zhao L,Ahmad M,Ehrengruber MU,Chen YE.Early stimulation and late inhibition of peroxisome proliferator-activated receptor γ(PPARγ)gene expression by transforming growth factor β in human aortic smooth muscle cells:role of early growth-response factor-1(Egr-1),activator protein 1(AP1)and Smads.Biochem J 2003; 370:1019-1025.
  • [9]Bishop-Bailey D,Hla T,Warner TD.Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-γ ligand therapy.Cire Res 2002; 91(3):210-213.
  • [10]Bruemmer D,Yin F,Liu J,Berger JP,Sakai T,Blaschke F,Fleck E,Van herle AJ,Fornan BM,Law RE.Regulation of the growth arrest and DNA damage-inducible gene 45(GADD45)by peroxisome proliferator activated receptor gamma in vascular smooth muscle cells.Circ Res 2003;93(4):e38-e47
  • [11]Pascual G,Sullivan AL,Ogawa S,Gamliel A,Perissi V,Rosenfeld MG,Glass CK.Anti-inflammatory and antidiabetic roles of PPARgamma.Novartis Found Symp 2007;286:183-196; discussion 196-203.
  • [12]Wakino S,Kintscher U,Liu Z,Kim S,Yin F,Ohba M,Kxoki T,Schonthal AH,Hsueh WA,Law RE.Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cipl)by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.J Biol Chem 2001; 276(50):47650-47657.
  • [13]Hupfeld C J,Weiss RH.TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.Am J Physiol Endocrinol Metab 2001; 281(2):E207-E216.
  • [14]Abe M,Haseguwa K,Wada H,Morimoto T,Yanazume T,Kawamura T,Hirai M,Furukawa Y,Kita T.GATA-6 is involved in PPA Rgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells.Arterioscler Thromb Vasc Biol2003; 23(3):404-410.
  • [15]Lim HJ,Lee KS,Lee S,Park JH,Choi HE,Go SH,Kwak HJ,Park HY.15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells.Toxicol Appl Pharmacol 2007; 223(1):20-27.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn